Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia
Open Access
- 1 January 2011
- journal article
- review article
- Published by Springer Nature in Chinese Medicine
- Vol. 6 (1) , 15
Abstract
Alzheimer's disease and vascular dementia are two major diseases associated with dementia, which is common among the elderly. While the etiology of dementia is multi-factorial and complex, neurodegeneration may be the major cause of these two diseases. Effective drugs for treating dementia are still to be discovered. Current western pharmacological approaches against neurodegeneration in dementia develop symptom-relieving and disease-modifying drugs. Current integrative and holistic approaches of Chinese medicine to discovering drugs for neurodegeneration in dementia include (1) single molecules from the herbs, (2) standardized extracts from a single herb, and (3) herbal formula with definite composition. This article not only reviews the concept of dementia in western medicine and Chinese medicine but also evaluates the advantages and disadvantages of these approaches.Keywords
This publication has 52 references indexed in Scilit:
- New Perspectives on Chinese Herbal Medicine (Zhong‐Yao) Research and DevelopmentEvidence-Based Complementary and Alternative Medicine, 2011
- Anti-aging herbal medicine—How and why can they be used in aging-associated neurodegenerative diseases?Ageing Research Reviews, 2010
- Polysaccharides from Wolfberry Antagonizes Glutamate Excitotoxicity in Rat Cortical NeuronsCellular and Molecular Neurobiology, 2009
- Ginkgo biloba for cognitive impairment and dementiaCochrane Database of Systematic Reviews, 2009
- Ginkgo biloba for Prevention of DementiaA Randomized Controlled TrialJAMA, 2008
- Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and preventionJournal of Cellular and Molecular Medicine, 2008
- Use of Anti-aging Herbal Medicine, Lycium barbarum, Against Aging-associated Diseases. What Do We Know So Far?Cellular and Molecular Neurobiology, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-α in intracerebroventricular β-amyloid-(1–40) infused rats and human embryonic kidney 293 Swedish mutant cellsNeuroscience Letters, 2004
- The Canadian Study of Health and AgingStroke, 1997